
Systemic sclerosis (SSc) is a rare multisystem autoimmune disease characterized by vasculopathy, immune dysregulation, and progressive fibrosis. Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is a common complication of SSc. Dupilumab, a humanized monoclonal antibody targeting interleukin-4 receptor alpha (IL-4Rα), suppresses the IL-4/IL-13 signaling as well as type 2 inflammatory responses. This study aimed to evaluate the anti-inflammatory and antifibrotic effects of anti-IL-4Rα antibody in SSc-ILD and to elucidate its underlying mechanisms. An in vitro model of THP-1 cells was established to evaluate the effects of dupilumab on the profibrotic phenotypic transition of macrophages. Concurrently, a hypochlorous acid (HOCl)-induced SSc-ILD mouse model was established to assess the in vivo efficacy of anti-IL-4Rα antibody and explore possible mechanism. In vitro, dupilumab suppressed IL-4/IL-13-induced profibrotic differentiation of macrophages. In vivo, IL-4/IL-13 blockade improved pulmonary function and radiographic outcomes, mitigated fibrosis and collagen deposition in the lungs and skin, reduced inflammatory cytokines levels in bronchoalveolar lavage fluid (BALF) and serum, and downregulated the expression of proinflammatory and profibrotic factors in the lungs and BALF. Mechanistically, anti-IL-4Rα antibody inhibited the activation of TGF-β1/Smad and JAK/STAT signaling pathways in lung tissue. Anti-IL-4Rα antibody attenuated HOCl-induced pulmonary inflammation and fibrosis in mice. These therapeutic effects may be mediated by suppressing the activation of the TGF-β1-Smad and JAK-STAT signaling. These findings support dupilumab as a promising therapeutic candidate for SSc-ILD patients. Not applicable
Positive endexpiratory pressure (PEEP) stabilizes functional residual capacity and gas exchange during non-invasive ventilation (NIV) in very preterm (VPT) infants. It is recommended as first-line respiratory support in guidelines around the world to avoid the harms of mechanical ventilation. The most effective PEEP to stabilize VPT infants within their oxygen saturation (SpO2) target and to avoid the adverse consequences of frequent fluctuations in oxygenation is unknown. This study assessed the efficacy of a PEEP set +3cmH2O higher during NIV compared to the actual PEEP to keep VPT infants within the SpO2 target. This prospective single-center real-life randomized cross-over trial executed in a level 3 neonatal intensive care unit assigned VPT infants in random sequence to actual (4–6 cmH2O) and higher (7–9 cmH2O) PEEP for 24 hours each. The primary outcome was time spent within the SpO2 target (88–95
Interstitial lung disease (ILD) is a group of heterogeneous diffuse pulmonary diseases that share similar pathological manifestations, including lung injury, inflammation and fibrosis, despite their distinct etiologies and comorbidities. Most of ILDs ultimately progress to pulmonary fibrosis (PF) with irreversible damage to lung tissue. Recent studies have recognized that an imbalance between pro- and anti-fibrotic signals plays a pivotal role in the occurrence and persistence of tissue fibrosis, including PF. TGF-βs present the most potent pro-fibrotic signaling, while bone morphogenetic proteins (BMPs)-mediated signaling, especially BMP-7, exerts a major anti-fibrotic action by opposing TGF-β signaling in fibrosis of liver, kidneys and heart. Although BMP-4 has been reported to be involved in PF, its specific regulatory mechanisms have not been fully explored. In this study, we determined the function of BMP-4 in lung injury, inflammation and fibrosis and explored the underlying mechanism. The expression of BMP-4 was decreased in human and mouse (bleomycin-induced) fibrotic lung tissues. Moreover, BMP-4 receptors and downstream signaling molecules were downregulated in mouse fibrotic lung tissues. Oppositely, expression of TGF-β1, -β2, -β3, TGF-β receptors and their signaling molecules was elevated in mouse fibrotic lung tissues. Adenovirus-mediated BMP-4 expression attenuated bleomycin-induced lung oxidative injury, inflammation and fibrosis in mice. Recombinant BMP-4 inhibited TGF-β1-induced macrophage activation, fibroblast differentiation into myofibroblasts, epithelial-to-mesenchymal transition and endothelial-to-mesenchymal transition in vitro. Furthermore, BMP-4 mitigated the increases in TGF-β-associated signaling molecule expression while reversing the decreases of BMP-associated signaling molecules in fibrotic mouse lungs and TGF-β1-treated cells. Taken together, our study provides substantial evidence for the protective function of BMP-4 in lung oxidative injury, inflammation and fibrosis by restoring the imbalance between BMP and TGF-β signaling.
Age is an important determinant in severe asthma phenotypes, disease trajectories, and treatment response. However, longitudinal analyses of clinical outcomes stratified by age group across the full adult age spectrum remain largely absent from the literature. With the emergence of clinical remission as an additional treatment target, understanding whether remission is equally attainable across age groups in real-world practice has become clinically important. This longitudinal analysis included 288 adult patients with severe asthma and complete data at baseline (V0), 12 months (V1), and 24 months (V2) from the Swiss Severe Asthma Registry (SSAR), an ongoing prospective cohort study. Patients were stratified into five age groups: 18–30, 31–50, 51–65, 66–75, and > 75 years. Individual remission components were: asthma control (ACT ≥ 20), preserved lung function (FEV1 > 80
Ambient air pollution is a major environmental determinant of respiratory health. Evidence linking long‑term particulate matter exposure to incident asthma remains limited among middle‑aged and older adults in China. We used data from the China Health and Retirement Longitudinal Study (CHARLS), enrolling 10,672 adults aged ≥ 45 years who were free of asthma at baseline. Time-varying annual average concentrations of PM1, PM2.5, PM10, O₃, and NO₂ in 2010 were assigned to participants based on residential geocodes with a high-resolution (1 km × 1 km) air pollution dataset. Incident asthma was identified through follow-up surveys conducted in 2013, 2015, 2018, and 2020. Conventional Cox proportional hazards model and time-varying Cox model were applied to estimate hazard ratios (HRs) and 95